EAM
BOLD
Eventide Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-499,000
| Closed | -$14M | – | 142 |
|
|
2019
Q3 | $14M | Hold |
499,000
| – | – | 0.46% | 68 |
|
|
2019
Q2 | $18.9M | Hold |
499,000
| – | – | 0.57% | 65 |
|
|
2019
Q1 | $19.5M | Buy |
499,000
+224,000
| +81% | +$8.74M | 0.67% | 57 |
|
|
2018
Q4 | $5.86M | Hold |
275,000
| – | – | 0.26% | 84 |
|
|
2018
Q3 | $10.9M | Hold |
275,000
| – | – | 0.4% | 74 |
|
|
2018
Q2 | $10.5M | Buy |
275,000
+5,000
| +2% | +$191K | 0.44% | 69 |
|
|
2018
Q1 | $8.11M | Buy |
270,000
+45,000
| +20% | +$1.35M | 0.38% | 70 |
|
|
2017
Q4 | $7.03M | Hold |
225,000
| – | – | 0.37% | 71 |
|
|
2017
Q3 | $6.3M | Hold |
225,000
| – | – | 0.36% | 72 |
|
|
2017
Q2 | $4.3M | Hold |
225,000
| – | – | 0.27% | 75 |
|
|
2017
Q1 | $3.83M | Hold |
225,000
| – | – | 0.25% | 80 |
|
|
2016
Q4 | $4.11M | Hold |
225,000
| – | – | 0.27% | 75 |
|
|
2016
Q3 | $4.01M | Buy |
+225,000
| New | +$4.01M | 0.24% | 74 |
|